Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2372071383;71384;71385 chr2:178574974;178574973;178574972chr2:179439701;179439700;179439699
N2AB2207966460;66461;66462 chr2:178574974;178574973;178574972chr2:179439701;179439700;179439699
N2A2115263679;63680;63681 chr2:178574974;178574973;178574972chr2:179439701;179439700;179439699
N2B1465544188;44189;44190 chr2:178574974;178574973;178574972chr2:179439701;179439700;179439699
Novex-11478044563;44564;44565 chr2:178574974;178574973;178574972chr2:179439701;179439700;179439699
Novex-21484744764;44765;44766 chr2:178574974;178574973;178574972chr2:179439701;179439700;179439699
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACC
  • RefSeq wild type template codon: TGG
  • Domain: Ig-130
  • Domain position: 84
  • Structural Position: 173
  • Q(SASA): 0.4797
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/I None None 0.997 D 0.776 0.468 0.61789491966 gnomAD-4.0.0 1.20032E-06 None None None None N None 0 0 None 0 0 None 0 0 0 0 3.66327E-05
T/S rs1709538154 None 0.362 N 0.363 0.14 0.340032825777 gnomAD-4.0.0 1.59251E-06 None None None None N None 5.65803E-05 0 None 0 0 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1045 likely_benign 0.1058 benign -0.791 Destabilizing 0.898 D 0.524 neutral D 0.525978856 None None N
T/C 0.3628 ambiguous 0.3799 ambiguous -0.548 Destabilizing 1.0 D 0.71 prob.delet. None None None None N
T/D 0.3741 ambiguous 0.3823 ambiguous -0.33 Destabilizing 0.995 D 0.721 prob.delet. None None None None N
T/E 0.3084 likely_benign 0.3145 benign -0.222 Destabilizing 0.995 D 0.718 prob.delet. None None None None N
T/F 0.227 likely_benign 0.228 benign -0.538 Destabilizing 0.999 D 0.778 deleterious None None None None N
T/G 0.3185 likely_benign 0.3202 benign -1.143 Destabilizing 0.966 D 0.679 prob.neutral None None None None N
T/H 0.1892 likely_benign 0.2005 benign -1.318 Destabilizing 1.0 D 0.75 deleterious None None None None N
T/I 0.1446 likely_benign 0.1447 benign 0.089 Stabilizing 0.997 D 0.776 deleterious D 0.533406261 None None N
T/K 0.2092 likely_benign 0.2185 benign -0.53 Destabilizing 0.995 D 0.721 prob.delet. None None None None N
T/L 0.1009 likely_benign 0.102 benign 0.089 Stabilizing 0.983 D 0.669 neutral None None None None N
T/M 0.0962 likely_benign 0.0941 benign 0.02 Stabilizing 1.0 D 0.721 prob.delet. None None None None N
T/N 0.1073 likely_benign 0.111 benign -0.802 Destabilizing 0.993 D 0.682 prob.neutral N 0.501389843 None None N
T/P 0.4852 ambiguous 0.4507 ambiguous -0.171 Destabilizing 0.997 D 0.771 deleterious N 0.502724309 None None N
T/Q 0.2075 likely_benign 0.2213 benign -0.725 Destabilizing 0.998 D 0.763 deleterious None None None None N
T/R 0.1873 likely_benign 0.1885 benign -0.574 Destabilizing 0.995 D 0.767 deleterious None None None None N
T/S 0.1101 likely_benign 0.1116 benign -1.088 Destabilizing 0.362 N 0.363 neutral N 0.495519876 None None N
T/V 0.1217 likely_benign 0.1246 benign -0.171 Destabilizing 0.983 D 0.604 neutral None None None None N
T/W 0.5708 likely_pathogenic 0.5548 ambiguous -0.586 Destabilizing 1.0 D 0.725 prob.delet. None None None None N
T/Y 0.2138 likely_benign 0.2228 benign -0.269 Destabilizing 0.999 D 0.771 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.